Feature
When a beating heart slips into an irregular, life-threatening rhythm, the treatment is well known: deliver a burst of electric current from a pacemaker or defibrillator. But because the electricity itself can cause pain, tissue damage and other serious side-effects, a Johns Hopkins-led research team wants to replace these jolts with a kinder, gentler remedy: light.
September 06, 2013
Technology
Philips showcased several new products at the European Society of Cardiology (ESC) 2013, including a new stress test system and a new cardiac PACS solution.
September 05, 2013Feature
Use of the novel anticoagulant otamixaban did not reduce ischemic events compared with unfractionated heparin plus eptifibatide but increased bleeding among patients with non–ST-segment elevation acute coronary syndromes undergoing a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), according to a clinical study published by JAMA. The study was released early online to coincide with its presentation at the European Society of Cardiology Congress 2013.
September 05, 2013Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024Feature
Transcatheter aortic valve implantation (TAVI) is feasible in patients with bicuspid aortic valve (BV), according to research presented at European Society of Cardiology (ESC) Congress 2013 by Dr. Timm Bauer from Germany. The findings open up a new treatment possibility in patients with BV, which has been considered a contraindication for TAVI.
September 05, 2013
News
September 5, 2013 — Scientists at Rice University have trapped bismuth in a nanotube cage to tag stem cells for X-ray tracking. Details of the work by a team from Rice and collaborators at the University of Houston, St. Luke's Episcopal Hospital and the Texas Heart Institute appear in the Journal of Materials Chemistry B.
September 05, 2013Feature
Researchers announced this week that an attempt to expand cardiac resynchronization therapy (CRT) to include more patients with heart failure has failed and an international clinical trial ended early to prevent potential harm to patients.
September 05, 2013Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
September 5, 2013 — ITC Nexus Holding Co., a company in hemostasis management and point-of-care (POC) testing, announced it has acquired Accumetrics, a specialist in assessing patient response to all major antiplatelet therapies. Terms of the transaction were not disclosed.
September 05, 2013
News
HeartWare International Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to commence enrollment in an additional patient cohort for ENDURANCE, the company's pivotal, destination therapy clinical study.
September 05, 2013
Technology
Terumo has introduced the GlideSheath Slender Hydrophilic Introducer Sheath, a 6 French sheath that has the outer diameter of a 5 French sheath. Its narrower profile makes it optimal for radial access, especially in women with smaller radial access.
September 04, 2013Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
C. R. Bard Inc. has entered into a definitive merger agreement to acquire Rochester Medical Corp. at a price of $20 per share, or approximately $262 million in the aggregate. The Rochester Medical board of directors unanimously approved the agreement and will recommend that the company's shareholders approve the transaction.
September 04, 2013News
Based on its recent analysis of the cardiology informatics market, Frost & Sullivan recognizes Ascend HiT with the 2013 North America Frost & Sullivan Award for Customer Value Leadership. With the introduction of CardioAnalytics, Ascend has proved that it is at the vanguard of the cardiology market's efforts to enhance quality and analytics. This product complements and extends the best-of-breed Ascend CV reporting products, and in the process, positions the company to deliver one of the most crucial elements of the cardiology value chain—cardiovascular procedural reporting.
September 04, 2013
Feature
September 3, 2013 — St. Jude Medical Inc. announced the CE mark approval of its next-generation EnligHTN renal denervation system for treating patients with drug-resistant, uncontrolled hypertension. The EnligHTN system was display during the 2013 European Society of Cardiology (ESC) meeting Aug. 31 to Sept. 3.
September 03, 2013Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
St. Jude Medical Inc. today announced U.S. Food and Drug Administration (FDA) approval and first use of MediGuide Enable Ablation Catheters. The ablation catheters, which are used to treat specific irregular heartbeats, expand the MediGuide platform for St. Jude Medical.
September 03, 2013
News
Avinger Inc. has received CE Mark approval for Pantheris – a system that combines directional atherectomy capabilities with real-time intravascular visualization to remove plaque from blocked arteries. Pantheris is designed to remove the blockage while avoiding the disruption of normal arterial wall structures. This new type of image-guided atherectomy is referred to as lumectomy. Currently, approximately 200 million patients worldwide suffer from peripheral artery disease (PAD).
September 03, 2013News
A listing of remote image viewing systems being shown at RSNA 2013
September 01, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now